Javier Bara-Casaus

Javier Bara-Casaus

Auto-generated profile, based on publicly available information

Javier Bara-Casaus

School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Dental and Maxillofacial Institute. Hospital Universitari Sagrat Cor, Grupo Quironsalud, Barcelona, Spain; Department of Oral and Maxillofacial Surgery, University Hospital of Mutua Terrassa, University of Barcelona, Terrassa, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
BGBassel Traboulsi Garet
Bassel Traboulsi Garet
Adrià Jorba-GarcíaAdrià Jorba-García
Adrià Jorba-García
JBJavier Bara-Casaus
Javier Bara-Casaus
OCOctavi Camps-Font
Octavi Camps-Font
EVEduard Valmaseda-Castellon
Eduard Valmaseda-Castellon
MSMª Ángeles Sánchez-Garcés
Mª Ángeles Sánchez-Garcés

14 February 2024 in Physiotherapy Theory and Practice
Verified
Journal Article
Closed access
CMCristian Justribó Manion
Cristian Justribó Manion
JMJuan Andrés Mesa-Jiménez
Juan Andrés Mesa-Jiménez
JBJavier Bara-Casaus
Javier Bara-Casaus
JZJuan-Carlos Zuil-Escobar
Juan-Carlos Zuil-Escobar
KWKatarzyna Wachowska
Katarzyna Wachowska
GÁGerard Álvarez-Bustins
Gerard Álvarez-Bustins
Previous studies have evaluated the implementation of behavioral approaches in individuals with chronic temporomandibular disorders (TMDs). To evaluate the benefits of a behavioral approach to craniofacial pain. Second, we assessed the benefits of kinesiophobia, catastrophizing, mouth opening without pain, and forward head posture. Individuals with chronic TMDs were treated for five weeks. The intervention group (n = 17) underwent pain neuroscience education, manual therapy, and therapeutic exercise, whereas the control group (n = 17) underwent manual therapy only. Outcomes were evaluated immediately, at seven and 19 weeks follow-up. The assessment tools used were the Craniofacial Pain Disability Inventory, Pain Catastrophizing Scale, Tampa Scale for Kinesiophobia, Mandibular Range of Motion Scale, and Cervical Range of Motion Tool. The interventions did not influence the differences in the improvements between the groups observed for craniofacial pain disability (inter-subject p 0.4). The intervention had a moderate influence on the improvement of kinesiophobia and catastrophizing (Inter-subject p 0.09 and 0.1 respectively) with a clinically significant effect size (Estimated mean (EM) -8.6 standard deviation (SD) ±3.48 p 0.019; and EM -7.6 SD ± 5.11 p 0.15 respectively). The behavioral approach improved catastrophizing and kinesiophobia outcomes in individuals with chronic TMDs.

28 May 2024 in Clinical Oral Investigations
Verified
Journal Article
Open access
PDF file
NBNatalia Bara-Gaseni
Natalia Bara-Gaseni
Adrià Jorba-GarcíaAdrià Jorba-García
Adrià Jorba-García
JAJavier Alberdi-Navarro
Javier Alberdi-Navarro
RFRui Figueiredo
Rui Figueiredo
JBJose-Javier Bara-Casaus
Jose-Javier Bara-Casaus
Objectives: This study aims to compare the histological outcomes of three distinct de-epithelialization methods used in (connective tissue grafts) CTG harvested from the palate. Materials and methods: An experimental study using nine cadaver head specimens was carried out to compare 3 different de-epithelialization techniques for CTG. Eighteen samples were randomly allocated to three study groups: bone scraper, diamond bur and extraoral removal with a scalpel. The main outcome variable was the graft surface percentage without epithelium remains. Additionally, the time employed, and the graft thickness were also measured. Results: Sixteen CTGs were analyzed. The extraoral scalpel group presented a total surface area with no epithelium of 58.84% (22.68) and a mean de-epithelialization time of 3.7 min; the intraoral diamond bur group had 88.24% (41.3) of the surface with no epithelium and took 1.455 min, and the intraoral bone scraper showed 97.98% (5.99) of surface without epithelium and a mean time of 0.815 min (P < 0.05). Histological analysis showed significant differences between the bone scraper and the extraoral group (P = 0.009). Conclusion: The de-epithelialization technique with a bone scraper seems to be the most effective and fastest de-epithelialization technique for CTG. These findings need to be confirmed in future clinical studies with larger samples. Clinical relevance: The use of bone scrapers, could be a simple, effective and fast technique to de-epithelialize connective tissue grafts harvested from the palatal area for both novice and experienced surgeons.

28 October 2024 in Physiotherapy Theory and Practice
Verified
Journal Article
Closed access
CMCristian Justribó Manion
Cristian Justribó Manion
Jordi Padrós-AugéJordi Padrós-Augé
Jordi Padrós-Augé
JMJuan Andrés Mesa-Jiménez
Juan Andrés Mesa-Jiménez
JBJavier Bara-Casaus
Javier Bara-Casaus
JZJuan-Carlos Zuil-Escobar
Juan-Carlos Zuil-Escobar
GBGerard Alvarez Bustins
Gerard Alvarez Bustins
Chronic painful temporomandibular disorders (TMD) are a functional pain syndrome that embodies a spectrum of clinical manifestations and expresses great complexity through the coexistence of multiple comorbidities. Evaluate the prevalence of pain comorbidities, explore the correlation between comorbidities, kinesiophobia, catastrophizing, and pain disability at baseline, and determine variables of interest for prediction response to physiotherapy interventions at different follow-up times. This is a secondary analysis of a previously conducted randomized controlled trial (RCT). Outcomes and covariables for this secondary analysis were collected from subjects with chronic TMD (≥3 months), based on the DC/TMD diagnostic criteria, assigned to a multimodal treatment and a second manual therapy control group. The participants underwent follow-up assessment at 7 and 19 weeks. The outcomes (dependent variables) for these analyses were craniofacial pain disability, catastrophizing, and kinesiophobia. However, these outcomes were also used as covariables of interest in addition to comorbidity prevalence and severity at baseline for different analyses. We performed linear regression analyses to determine the association between our outcomes and covariables at baseline and at different follow-ups. Comorbidity severity explained craniofacial pain disability at baseline, showing a strong correlation (Standardized B: 0.40, p-value: 0.017). Higher comorbidity severity, led to higher craniofacial pain score. Comorbidity severity and baseline catastrophizing predicted a better response to treatment for craniofacial pain improvements at short and long term (R2 .22, p-value : 0.009 and R2 .19, p-value: 0.02 respectively). This study provides insight into the prevention and clinical management of chronic pain related to TMD.